The role of ABC transporters in progression and clinical outcome of colorectal cancer

Mutagenesis

Volumn 27, Issue 2, 2012, Pages 187-196

  Hlavata, I ^a,b   Mohelnikova Duchonova, B ^a   Vaclavikova, R ^a   Liska, V ^b   Pitule, P ^b   Novak, P ^b   Bruha, J ^b   Vycital, O ^b   Holubec, L ^b   Treska, V ^b   Vodicka, P ^c   Soucek, P ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A12; ABC TRANSPORTER A13; ABC TRANSPORTER B11; ABC TRANSPORTER B6; ABC TRANSPORTER B9; ABC TRANSPORTER C1; ABC TRANSPORTER C2; ABC TRANSPORTER C7; ABC TRANSPORTER C8; ABC TRANSPORTER D4; ABC TRANSPORTER E1; ABC TRANSPORTER G5; ABC TRANSPORTER G8; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CANCER TISSUE; COLON; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE INTERVAL; DOWN REGULATION; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECTUM; TREATMENT OUTCOME; UPREGULATION;

AGED; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COLON; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PILOT PROJECTS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE;

EID: 84856812987     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger075     Document Type: Article

References (65)

1. Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C. D. and Parkin, D. (2010) GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon, France, International Agency for Research on Cancer. http://globocan.iarc.fr (accessed September 8, 2010).
2. Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. and Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer\-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85. (Pubitemid 30451850)
3. Aaltonen, L., Johns, L., Jarvinen, H., Mecklin, J. P. and Houlston, R. (2007) Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin. Cancer Res., 13, 356-361. (Pubitemid 46121890)
4. Watson, A. J. and Collins, P. D. (2011) Colon cancer: a civilization disorder. Dig. Dis., 29, 222-228.
5. Soucek, P. (2008) Xenobiotics. In Schwab, M. (ed.), Encyclopedia of Cancer. 2nd edn. Springer-Verlag, New York, NY.
6. Cole, S. P., Bhardwaj, G., Gerlach, J. H. et al. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654. (Pubitemid 23012438)
7. Mendoza, J. L., Urcelay, E., Lana, R. et al. (2007) MDR1 polymorphisms and response to azathioprine therapy in patients with Crohn's disease. Inflamm. Bowel Dis., 13, 585-590. (Pubitemid 46799643)
8. Higgins, C. F. (1992) ABC transporters: from microorganisms to man. Annu. Rev. Cell Biol., 8, 67-113. (Pubitemid 23000992)
9. Kaminski, W. E., Piehler, A. and Wenzel, J. J. (2006) ABC A-subfamily transporters: structure, function and disease. Biochim. Biophys. Acta, 1762, 510-524.
10. Hyde, S. C., Emsley, P., Hartshorn, M. J. et al. (1990) Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature, 346, 362-365.
11. Gottesman, M. M., Fojo, T. and Bates, S. E. (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer, 2, 48-58. (Pubitemid 37328807)
12. Ejendal, K. F. and Hrycyna, C. A. (2002) Multidrug resistance and cancer: the role of the human ABC transporter ABCG2. Curr. Protein Pept. Sci., 3, 503-511. (Pubitemid 35157721)
13. Broccardo, C., Luciani, M. and Chimini, G. (1999) The ABCA subclass of mammalian transporters. Biochim. Biophys. Acta, 1461, 395-404.
14. Ohtsuki, S., Kamoi, M., Watanabe, Y., Suzuki, H., Hori, S. and Terasaki, T. (2007) Correlation of induction of ATP binding cassette transporter A5 (ABCA5) and ABCB1 m RNAs with differentiation state of human colon tumor. Biol. Pharm. Bull., 30, 1144-1146. (Pubitemid 46883871)
15. Choudhuri, S. and Klaassen, C. D. (2006) Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int. J. Toxicol., 25, 231-259. (Pubitemid 44034685)
16. Hoffmeyer, S., Burk, O., von Richter, O. et al. (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc.Natl Acad. Sci. U S A, 97, 3473-3478. (Pubitemid 30183327)
17. Sharom, F. J. (2008) ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics, 9, 105-127. (Pubitemid 351560534)
18. Marzolini, C., Paus, E., Buclin, T. and Kim, R. B. (2004) Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin. Pharmacol. Ther., 75, 13-33. (Pubitemid 38130115)
19. Vaclavikova, R., Nordgard, S. H., Alnaes, G. I. et al. (2008) Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients. Pharmacogenet. Genomics, 18, 263-273. (Pubitemid 351323241)
20. De Iudicibus, S., De Pellegrin, A., Stocco, G., Bartoli, F., Bussani, R. and Decorti, G. (2008) ABCB1 gene polymorphisms and expression of P-glycoprotein and long-term prognosis in colorectal cancer. Anticancer Res., 28, 3921-3928.
21. Ding, Z., Yang, L., Xie, X., Xie, F., Pan, F., Li, J., He, J. and Liang, H. (2010) Expression and significance ofhypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells. J. Cancer Res. Clin. Oncol., 136, 1697-1707.
22. Johnsson, A., Vallon-Christensson, J., Strand, C., Litman, T. and Eriksen, J. (2005) Gene expression profiling in chemoresistant variants of three cell lines of different origin. Anticancer Res., 25, 2661-2668. (Pubitemid 41044644)
23. Kasajima, A., Sers, C., Sasano, H. et al. (2010) Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer. Hum. Pathol., 41, 1758-1769.
24. Zhou, S. F., Wang, L. L., Di, Y. M., Xue, C. C., Duan, W., Li, C. G. and Li, Y. (2008) Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr. Med. Chem., 15, 1981-2039.
25. Leslie, E. M., Haimeur, A. and Waalkes, M. P. (2004) Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required. J. Biol. Chem., 279, 32700-32708. (Pubitemid 39014729)
26. Smitherman, P. K., Townsend, A. J., Kute, T. E. and Morrow, C. S. (2004) Role of multidrug resistance protein 2 (MRP2, ABCC2) in alkylating agent detoxification: MRP2 potentiates glutathione S-transferase A1-1-mediated resistance to chlorambucil cytotoxicity. J. Pharmacol. Exp. Ther., 308, 260-267. (Pubitemid 38090726)
27. Haimeur, A., Conseil, G., Deeley, R. G. and Cole, S. P. (2004) The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr. Drug Metab., 5, 21-53. (Pubitemid 38294344)
28. Fujita, K., Nagashima, F., Yamamoto, W. etal. (2008) Association of ATP-binding cassette, sub-family C, number 2 (ABCC2) genotype with pharmacokinetics of irinotecan in Japanese patients with metastatic colorectal cancer treated with irinotecan plus infusional 5-fluorouracil/ leucovorin (FOLFIRI). Biol. Pharm. Bull., 31, 2137-2142.
29. Hinoshita, E., Uchiumi, T., Taguchi, K., Kinukawa, N., Tsuneyoshi, M., Maehara, Y., Sugimachi, K. and Kuwano, M. (2000) Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin. Cancer Res., 6, 2401-2407. (Pubitemid 30399208)
30. Theile, D., Grebhardt, S., Haefeli, W. E. and Weiss, J. (2009) Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy. Biochem. Pharmacol., 78, 1366-1373.
31. Pratt, S., Shepard, R. L., Kandasamy, R. A., Johnston, P. A., Perry, W., III and Dantzig, A. H. (2005) The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol. Cancer Ther., 4, 855-863. (Pubitemid 40767130)
32. Gradilone, A., Pulcinelli, F. M., Lotti, L. V. et al. (2008) Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy. Curr. Cancer Drug Targets, 8, 414-420.
33. Gazzaniga, P., Gradilone, A., Petracca, A., Nicolazzo, C., Raimondi, C., Iacovelli, R., Naso, G. and Cortesi, E. (2010) Molecular markers in circulating tumour cells from metastatic colorectal cancer patients. J. Cell. Mol. Med., 14, 2073-2077.
34. Guo, Y., Kotova, E., Chen, Z. S., Lee, K., Hopper-Borge, E., Belinsky, M. G. and Kruh, G. D. (2003) MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethox-yethyl)adenine. J. Biol. Chem., 278, 29509-29514. (Pubitemid 36962331)
35. Shani, N. and Valle, D. (1996) A Saccharomyces cerevisiae homolog of the human adrenoleukodystrophy transporter is a heterodimer of two half ATP-binding cassette transporters. Proc. Natl Acad. Sci. U S A, 93, 11901-11906. (Pubitemid 26347221)
36. Campa, D., Pardini, B., Naccarati, A. et al. (2008) A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer. Mutat. Res., 645, 56-60.
37. Dietrich, C. G., Vehr, A. K., Martin, I. V., Gaßler, N., Rath, T., Roeb, E., Schmitt, J., Trautwein, C. and Geier, A. (2011) Downregulation ofbreast cancer resistance protein in colon adenomas reduces cellular xenobiotic resistance and leads to accumulation of a food-derived carcinogen. Int. J. Cancer, 129, 546-552.
38. Nakatomi, I., Yoshikawa, M., Oka, M. et al. (2001) Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells. Biochem. Biophys. Res. Commun., 288, 827-832. (Pubitemid 33140956)
39. Chikazawa, N., Tanaka, H., Tasaka, T., Nakamura, M., Tanaka, M., Onishi, H. and Katano, M. (2010) Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells. Anticancer Res., 30, 2041-2048.
40. Hostettler, L., Zlobec, I., Terracciano, L. and Lugli, A. (2010) ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients. World J. Gastroenterol., 16, 732-739.
41. Sobin, L. H. and Wittekind, C. (eds) (2002) TNM Classification of Malignant Tumors. 6th edn. Wiley-Liss, New York, NY.
42. Therasse, P., Arbuck, S. G., Eisenhauer, E. A. etal. (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl Cancer Inst., 92, 205-216.
43. Soucek, P., Anzenbacher, P., Skoumalova, I. and Dvorak, M. (2005) Expression of cytochrome P450 genes in CD34+ hematopoietic stem and progenitor cells. Stem Cells, 23, 1417-1422. (Pubitemid 41504929)
44. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A. and Speleman, F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol., 3, research0034.1-research0034.11.
45. Andersen, C. L., Jensen, J. L. and Ørntoft, T. F. (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res., 64, 5245-5250. (Pubitemid 39006544)
46. Bustin, S. A., Benes, V., Garson, J. A. et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem., 55, 611-622.
47. Pfaffl, M. W., Horgan, G. W. and Dempfle, L. (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in realtime PCR. Nucleic Acids Res., 30, e36.
48. Gupta, N., Martin, P. M., Miyauchi, S., Ananth, S., Herdman, A. V., Martindale, R. G., Podolsky, R. and Ganapathy, V. (2006) Down-regulation of BCRP/ABCG2 in colorectal and cervical cancer. Biochem. Biophys. Res. Commun., 343, 571-577.
49. Shichijo, S., Ishihara, Y., Azuma, K. et al. (2005) ABCE1, a member of ATP-binding cassette transporter gene, encodes peptides capable of inducing HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes in colon cancer patients. Oncol. Rep., 13, 907-913.
50. Anderle, P., Sengstag, T., Mutch, D. M., Rumbo, M., Praz, V., Mansourian, R., Delorenzi, M., Williamson, G. and Roberts, M. A. (2005) Changes in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axes. BMC Genomics, 6, 69.
51. Mutch, D. M., Anderle, P., Fiaux, M., Mansourian, R., Vidal, K., Wahli, W., Williamson, G. and Roberts, M. A. (2004) Regional variations in ABC transporter expression along the mouse intestinal tract. Physiol. Genomics, 17, 11-20. (Pubitemid 38924146)
52. Berggren, S., Gall, C., Wollnitz, N., Ekelund, M., Karlbom, U., Hoogstraate, J., Schrenk, D. and Lennernäs, H. (2007) Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine. Mol. Pharm., 4, 252-257. (Pubitemid 46640601)
53. Gutmann, H., Hruz, P., Zimmermann, C., Beglinger, C. and Drewe, J. (2005) Distribution of breast cancer resistance protein (BCRP/ABCG2) m RNA expression along the human GI tract. Biochem. Pharmacol., 70, 695-699. (Pubitemid 41058704)
54. Candeil, L., Gourdier, I., Peyron, D. et al. (2004) ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases. Int. J. Cancer, 109, 848-854. (Pubitemid 38500741)
55. Pantaleo, M. A., Astolfi, A., Nannini, M. et al. (2008) Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice. Br. J. Cancer, 99, 1729-1734.
56. König, J., Hartel, M., Nies, A. T., Martignoni, M. E., Guo, J., Büchler, M. W., Friess, H. and Keppler, D. (2005) Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. Int. J. Cancer, 115, 359-367. (Pubitemid 40663738)
57. Zhang, Z., Deng, X., Ren, X., Zhang, B., Chen, X., Yang, J., Ding, H., Sui, J. and Song, X. (2010) Expression ofmutant p53 and of the multidrug resistant proteins P-glycoprotein and glutathione S-transferase-pi correlated in colorectal adenocarcinoma. Scand. J. Gastroenterol., 45, 925-934.
58. Liu, H. G., Pan, Y. F., You, J., Wang, O. C., Huang, K. T. and Zhang, X. H. (2010) Expression of ABCG2 and its significance in colorectal cancer. Asian Pac. J. Cancer Prev., 11, 845-848.
59. Oguri, T., Bessho, Y., Achiwa, H., Ozasa, H., Maeno, K., Maeda, H., Sato, S. and Ueda, R. (2007) MRP8/ABCC11 directly confers resistance to 5-fluorouracil. Mol. Cancer Ther., 6, 122-127. (Pubitemid 46206674)
60. Sadahiro, S., Suzuki, T., Maeda, Y. et al. (2010) Molecular determinants of folate levels after leucovorin administration in colorectal cancer. Cancer Chemother. Pharmacol., 65, 735-742.
61. Schmidt, W. M., Kalipciyan, M., Dornstauder, E., Rizovski, B., Steger, G. G., Sedivy, R., Mueller, M. W. and Mader, R. M. (2004) Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling. Int. J. Cancer, 112, 200-212. (Pubitemid 39244359)
62. Hagmann, W., Jesnowski, R., Faissner, R., Guo, C. and Löhr, J. M. (2009) ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells. Pancreatology, 9, 136-144.
63. Park, S., Shimizu, C., Shimoyama, T. et al. (2006) Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res. Treat., 99, 9-17. (Pubitemid 44168598)
64. Ogawa, Y., Tsuda, H., Hai, E. et al. (2006) Clinical role of ABCF2 expression in breast cancer. Anticancer Res., 26, 1809-1814. (Pubitemid 43989436)
65. Zhang, W., Shannon, W. D., Duncan, J., Scheffer, G. L., Scheper, R. J. and Mc Leod, H. L. (2006) Expression of drug pathway proteins is independent of tumour type. J. Pathol., 209, 213-219. (Pubitemid 43805417)